The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors
Condition: Gastroesophageal Junction (GEJ) Adenocarcinoma Intervention: Drug: Q-1802 Injection,Oxaliplatin Injection,Capecitabine Sponsor: QureBio Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials
Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma Intervention: Drug: Carrilizumab, bevacizumab,capecitabine Sponsor: Second Affiliated Hospital of Guangzhou Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials
The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors
Condition: Gastroesophageal Junction (GEJ) Adenocarcinoma Intervention: Drug: Q-1802 Injection,Oxaliplatin Injection,Capecitabine Sponsor: QureBio Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials
Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma Intervention: Drug: Carrilizumab, bevacizumab,capecitabine Sponsor: Second Affiliated Hospital of Guangzhou Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials
The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors
Condition: Gastroesophageal Junction (GEJ) Adenocarcinoma Intervention: Drug: Q-1802 Injection,Oxaliplatin Injection,Capecitabine Sponsor: QureBio Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials
Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma Intervention: Drug: Carrilizumab, bevacizumab,capecitabine Sponsor: Second Affiliated Hospital of Guangzhou Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials
The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors
Condition: Gastroesophageal Junction (GEJ) Adenocarcinoma Intervention: Drug: Q-1802 Injection,Oxaliplatin Injection,Capecitabine Sponsor: QureBio Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials
Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma Intervention: Drug: Carrilizumab, bevacizumab,capecitabine Sponsor: Second Affiliated Hospital of Guangzhou Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials
